Ranitidine hydrochloride and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Ranitidine hydrochloride (ranitidine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Simvastatin, and have Indigestion.

The phase IV clinical study analyzes which people have Stroke when taking Ranitidine hydrochloride. It is created by eHealthMe based on reports of 75,820 people who have side effects when taking Ranitidine hydrochloride from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,315 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jul, 03, 2026

75,820 people reported to have side effects when taking Ranitidine hydrochloride.
Among them, 62 people (0.08%) have Stroke.

Could Ranitidine hydrochloride cause Stroke?

Among these 62 people:

How long have people been on Ranitidine hydrochloride when they have Stroke? *

What is the gender of people who have Stroke when taking Ranitidine hydrochloride? *

female: 58.62 %
male: 41.38 %

What is the age of people who have Stroke when taking Ranitidine hydrochloride? *

What are other drugs people take besides Ranitidine hydrochloride? *

What are other side effects people have besides Stroke? *

High Blood Pressure: 10 people, 16.13%
Dyspnea (difficult or laboured breathing): 9 people, 14.52%
Speech Impairment (Adult) (inability to speak (adult)): 8 people, 12.90%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 7 people, 11.29%
Fall: 5 people, 8.06%
Depression: 4 people, 6.45%
Chronic Kidney Disease: 4 people, 6.45%
Diarrhea: 4 people, 6.45%
Memory Loss: 4 people, 6.45%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 4.84%

What are the existing conditions these people have? *

Indigestion: 9 people, 14.52%
High Blood Cholesterol: 7 people, 11.29%
Abdominal Discomfort: 6 people, 9.68%
Ill-Defined Disorder: 5 people, 8.06%
High Blood Pressure: 5 people, 8.06%
Pain: 5 people, 8.06%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 6.45%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 6.45%
Osteoporosis (bones weak and more likely to break): 4 people, 6.45%
Nausea And Vomiting: 3 people, 4.84%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine hydrochloride:

Ranitidine hydrochloride (76,413 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,315 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Ranitidine hydrochloride) and Ranitidine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.